PILE: a candidate prognostic score in cancer patients treated with immunotherapy DC Guven, HC Yildirim, E Bilgin, OH Aktepe, H Taban, TK Sahin, IY Cakir, ... Clinical and Translational Oncology 23, 1630-1636, 2021 | 22 | 2021 |
The association between early changes in neutrophil-lymphocyte ratio and survival in patients treated with immunotherapy DC Guven, TK Sahin, E Erul, IY Cakir, E Ucgul, HC Yildirim, OH Aktepe, ... Journal of Clinical Medicine 11 (15), 4523, 2022 | 12 | 2022 |
The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme DC Guven, MS Aksun, IY Cakir, S Kilickap, N Kertmen Future Oncology 17 (32), 4405-4413, 2021 | 8 | 2021 |
The efficacy of immune checkpoint inhibitors in rare tumors: a systematic review of published clinical trials DC Guven, B Stephen, TK Sahin, IY Cakir, E Erul, S Aksoy Critical Reviews in Oncology/Hematology 174, 103700, 2022 | 7 | 2022 |
Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic DC Guven, F Ceylan, IY Cakir, E Cesmeci, B Sayinalp, B Yesilyurt, ... Supportive Care in Cancer 29, 4159-4164, 2021 | 7 | 2021 |
The association between albumin-globulin ratio (AGR) and survival in patients treated with immune checkpoint inhibitors DC Guven, OH Aktepe, MS Aksun, TK Sahin, G Kavgaci, E Ucgul, IY Cakir, ... Cancer Biomarkers 34 (2), 189-199, 2022 | 4 | 2022 |
Immunotherapy in the First‐Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta‐Analysis DC Guven, B Stephen, TK Sahin, IY Cakir, S Aksoy The Laryngoscope 134 (1), 7-17, 2024 | 2 | 2024 |
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates G Sandal Uzun, A Taghiyeva, İY Çakır, K Moral, GK Yardımcı, EÇ Bölek, ... International Journal of Rheumatic Diseases 27 (1), e14967, 2024 | | 2024 |
Factors that predict development of chronic kidney disease in patients with rheumatoid arthritis receiving biologic DMARDs and mortality rates. A Taghiyeva, İY Çakır, K Moral, GK Yardımcı, EÇ Bölek, B Farisoğulları, ... International Journal of Rheumatic Diseases, 2023 | | 2023 |
Use of molnupiravir in patients who developed SARS-CoV2-Infection during hospitalization GT Dizman, Y Çakır, G Korubük, G Metan, S Ünal Acta Medica 54 (3), 252-257, 2023 | | 2023 |
AB0954 IMPACT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH AS USING BIOLOGIC AGENTS GS Uzun, İY Çakir, E Bilgin, B Farisogullari, G Ayan, Z Özsoy, M Ekici, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1695-1695, 2023 | | 2023 |
Biyolojik tedavi alan romatoid artrit hastalarında kronik böbrek hastalığı; HÜR-BİO gerçek yaşam verisi. GS Uzun, A Taghiyeva, İY Çakır, K Moral, E Bilgin, GK Yardımcı, ... Journal of Turkish Society for Rheumatology 14, 2022 | | 2022 |
AB0353 bDMARD CHOICES FOR INFLAMMATORY ARTHRITIS WITH CHRONIC KIDNEY DISEASE; HUR-BIO REAL-LIFE REGISTRY GS Uzun, A Taghiyeva, İY Çakir, K Moral, E Bilgin, GK Yardimci, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 1303-1303, 2022 | | 2022 |
The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study DC Güven, HÇ Yildirim, E Erul, TK Şahin, IY Çakir, OH Aktepe, N Kertmen, ... Turkish journal of medical sciences 52 (5), 1551-1558, 2022 | | 2022 |
85P The association between diabetes and survival in patients treated with immunotherapy DC Guven, IY Cakir, TK Sahin, HC Yildirim, S Aksoy, M Erman, S Kilickap, ... Annals of Oncology 32, S1409, 2021 | | 2021 |
Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic DC Guven, F Ceylan, IY Cakir, E Cesmeci, B Sayinalp, B Yesilyurt, ... ANNALS OF ONCOLOGY 31, S932-S932, 2020 | | 2020 |
1505MO Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic DC Guven, F Ceylan, IY Cakir, E Cesmeci, B Sayinalp, B Yesilyurt, ... Annals of Oncology 31, S932, 2020 | | 2020 |
JOURNAL of ONCOLOGICAL SCIENCES C ŞİMŞEK, DC GÜVEN, F CEYLAN, İY ÇAKIR, TK ŞAHİN, Ö DİZDAR, ... | | |